666

ENERGENESIS BIOMEDICAL CO LTD

No trades
See on Supercharts
Market capitalization
‪4.23 B‬TWD
‪−260.38 M‬TWD
‪7.16 M‬TWD
Beta (1Y)
0.03

About ENERGENESIS BIOMEDICAL CO LTD

CEO
Han Min Chen
Headquarters
Taipei
Founded
2012
ISIN
TW0006657000
FIGI
BBG00LLVJY15
Energenesis Biomedical Co., Ltd. engages in the development of new drugs. Its business activities include sale of reagents, and testing and analysis services. It offers medicines for diabetic foot ulcers, and alopecia treatment. The company was founded by Jen Yi Chiu and Han Min Chen on August 28, 2012 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6657 is 55.9 TWD — it has increased by 0.54% in the past 24 hours. Watch ENERGENESIS BIOMEDICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange ENERGENESIS BIOMEDICAL CO LTD stocks are traded under the ticker 6657.
6657 stock is 1.81% volatile and has beta coefficient of 0.03. Track ENERGENESIS BIOMEDICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is ENERGENESIS BIOMEDICAL CO LTD there?
Yes, you can track ENERGENESIS BIOMEDICAL CO LTD financials in yearly and quarterly reports right on TradingView.
6657 stock has risen by 1.64% compared to the previous week, the month change is a 3.45% fall, over the last year ENERGENESIS BIOMEDICAL CO LTD has showed a 9.11% decrease.
6657 net income for the last quarter is ‪−62.33 M‬ TWD, while the quarter before that showed ‪−45.16 M‬ TWD of net income which accounts for −38.01% change. Track more ENERGENESIS BIOMEDICAL CO LTD financial stats to get the full picture.
Today ENERGENESIS BIOMEDICAL CO LTD has the market capitalization of ‪4.24 B‬, it has decreased by 2.55% over the last week.
No, 6657 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6657 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENERGENESIS BIOMEDICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
6657 reached its all-time high on Jul 26, 2023 with the price of 99.5 TWD, and its all-time low was 51.5 TWD and was reached on Apr 19, 2024. View more price dynamics on 6657 chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENERGENESIS BIOMEDICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENERGENESIS BIOMEDICAL CO LTD stock shows the strong sell signal. See more of ENERGENESIS BIOMEDICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENERGENESIS BIOMEDICAL CO LTD EBITDA is ‪−238.02 M‬ TWD, and current EBITDA margin is ‪−3.33 K‬%. See more stats in ENERGENESIS BIOMEDICAL CO LTD financial statements.